Abstract
The development of positron emission tomography radioligands for the GABAA /benzodiazepine receptor complex (GABAA receptor) labeled with (11) C and (18) F is examined. The review covers labeling strategies as well as brief biological evaluations of radioligands. In addition, we assess the special considerations that must be taken during a development program for radioligands targeting the GABAA receptor and explore some of the challenges that lie ahead.
Keywords:
F-18; GABA; benzodiazepine; radiochemistry; radioligand.
Copyright © 2013 John Wiley & Sons, Ltd.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Brain / diagnostic imaging*
-
Carbon Radioisotopes / chemistry
-
Fluorine Radioisotopes / chemistry
-
GABA-A Receptor Agonists / chemical synthesis*
-
GABA-A Receptor Agonists / pharmacology
-
GABA-A Receptor Antagonists / chemical synthesis*
-
GABA-A Receptor Antagonists / pharmacology
-
Humans
-
Isotope Labeling*
-
Positron-Emission Tomography
-
Radiopharmaceuticals / chemical synthesis*
-
Radiopharmaceuticals / pharmacology
-
Receptors, GABA-A / metabolism*
Substances
-
Carbon Radioisotopes
-
Fluorine Radioisotopes
-
GABA-A Receptor Agonists
-
GABA-A Receptor Antagonists
-
Radiopharmaceuticals
-
Receptors, GABA-A